Immunohistochemical identification of tumours of adipocytic differentiation using an antibody to aP2 protein.
AUTOR(ES)
Bennett, J H
RESUMO
AIM--To determine whether aP2 expression is a useful diagnostic marker in soft tissue tumour pathology. METHODS--A polyclonal antibody to aP2 was used to investigate the immunohistochemical expression of this protein in benign and malignant tumours of adipocytic differentiation and a wide variety of other neoplasms. RESULTS--aP2 was only expressed by lipoblasts (in all types of liposarcoma and in lipoblastomatosis) and by brown fat cells (in both hibernomas and normal periadrenal fetal fat). Other benign adipose tissue tumours and malignant connective tissue or epithelial tumours were distinguished from liposarcoma by the absence of staining for aP2. CONCLUSION--Identification of lipoblasts using markers of aP2 expression is of value in the differential diagnosis of benign and malignant adipose tissue tumours and in distinguishing liposarcomas from other malignant mesenchymal and epithelial neoplasms, some of which contain cells that morphologically resemble lipoblasts.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=502954Documentos Relacionados
- Expression of the mitochondrial uncoupling protein gene from the aP2 gene promoter prevents genetic obesity.
- Induction of aP2 gene expression by nonmetabolized long-chain fatty acids.
- Identification of ERF-1 as a member of the AP2 transcription factor family
- Expression of specific mRNAs during adipose differentiation: identification of an mRNA encoding a homologue of myelin P2 protein.
- Sulphur mustards inhibit binding of transcription factor AP2 in vitro.